Financhill
Back

Bionano Genomics Quote, Financials, Valuation and Earnings

Sell
43

BNGO
Bionano Genomics

Last Price:
1.02
Seasonality Move:
7.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Bionano Genomics Price Quote

$1.02
-0.05 (-4.67%)
(Updated: May 28, 2024 at 6:55 PM ET)

Bionano Genomics Key Stats

Sell
43
Bionano Genomics (BNGO) is a Sell

Day range:
$1.04 - $1.10
52-week range:
$0.71 - $8.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.93
P/B ratio:
0.86%

Volume:
646.7K
Avg. volume:
1.2M
1-year change:
-83.95%
Market cap:
$71.5M
Revenue:
$36.1M
EPS:
$-17.18

How Much Does Bionano Genomics Make?

Is Bionano Genomics Growing As A Company?

  • What Is Bionano Genomics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.18%
  • What Is Bionano Genomics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Bionano Genomics Stock Price Performance

  • Did Bionano Genomics Stock Go Up Last Month?
    Bionano Genomics share price went up by 40.59% last month
  • Did BNGO's Share Price Rise Over The Last Year?
    BNGO share price fell by -83.95% over the past 1 year

What Is Bionano Genomics 52-Week High & Low?

Bionano Genomics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bionano Genomics?

  • How Much Debt Does Bionano Genomics Have?
    Total long term debt quarterly is $29.1M
  • How Much Cash Does Bionano Genomics Have?
    Cash and short term investments quarterly total is $52.8M
  • What Is Bionano Genomics’s Book Value Per Share?
    Book value per share is 1.44

Is Bionano Genomics Cash Flow Positive?

  • What Is BNGO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.9M
  • What Is Bionano Genomics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $77.3M
  • What Is Bionano Genomics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $55.2M

Bionano Genomics Return On Invested Capital

  • Is Management Doing A Good Job?
    BNGO return on invested capital is -134.51%
  • What Is Bionano Genomics Return On Assets?
    ROA measures how assets are converting to revenues and is -101.44%
  • What Is BNGO Return On Equity?
    ROE is a measure of profitability and is -152.38%

Bionano Genomics Earnings Date & Stock Price

Bionano Genomics Competitors

  • Who Are Bionano Genomics's Competitors?
    Below is a list of companies who compete with Bionano Genomics or are related in some way:
    • Akoya Biosciences Inc (AKYA)
    • Azenta Inc (AZTA)
    • Bruker Corp (BRKR)
    • Harvard Bioscience Inc (HBIO)
    • Singular Genomics Systems Inc (OMIC)

Bionano Genomics Dividend Yield

Data Unavailable

Bionano Genomics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.24%
Revenue: 18.26% 3.27%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 6.67
Upside from Last Price: 523.05%

Major Shareholders

  • How many BNGO shares are owned by institutional investors?
    7.3M BNGO shares are owned by institutional investors
  • How many BNGO shares are owned by insiders?
    5.6M BNGO shares are owned by insiders